Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized Non-Inferiority Trial of Hypofractionated Radiotherapy for Locally Advanced Cervical Cancer in Uganda

NCT07276360 is registered in ClinicalTrials.gov with Uganda Cancer Institute as lead sponsor.

NCT NCT07276360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07276360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized Non-Inferiority Trial of Hypofractionated Radiotherapy for Locally Advanced Cervical Cancer in Uganda
Lead sponsor
Uganda Cancer Institute
Phase
Phase 2
Overall status
Recruiting
Start date
March 11, 2026
Completion date
January 2, 2029
Enrollment
278 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical adenocarcinoma, cervical adenosquamous carcinoma, cervical cancer, cervical small cell carcinoma, cervix cancer